RT Journal Article
SR Electronic
T1 Feeding infants below 29 weeks’ gestation with abnormal antenatal Doppler: analysis from a randomised trial
JF Archives of Disease in Childhood - Fetal and Neonatal Edition
JO Arch Dis Child Fetal Neonatal Ed
FD BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health
SP F6
OP F11
DO 10.1136/archdischild-2013-304393
VO 99
IS 1
A1 Stephen Kempley
A1 Neelam Gupta
A1 Louise Linsell
A1 Jon Dorling
A1 Kenny McCormick
A1 Paul Mannix
A1 Edmund Juszczak
A1 Peter Brocklehurst
A1 Alison Leaf
A1 on behalf of the ADEPT Trial Collaborative Group
YR 2014
UL http://fn.bmj.com/content/99/1/F6.abstract
AB Objective To describe feeding and gastrointestinal outcomes in growth-restricted infants <29 weeks’ gestation and to determine the rate of feed advancement which they tolerate. Design Analysis of prospectively collected data from a randomised feeding trial, the Abnormal Doppler Enteral Prescription Trial (ADEPT). Setting 54 neonatal units in the UK and Ireland. Participants 404 preterm, growth-restricted infants with abnormal antenatal Doppler studies from ADEPT. 83 infants <29 weeks and 312 infants ≥29 weeks’ gestation were included in this analysis. Interventions In ADEPT, infants were randomised to start milk ‘early’ on day 2 after birth, or ‘late’ on day 6. Subsequent feed advancement followed a regimen, which should have achieved full feeds by day 16 in the early and day 20 in the late group. Main outcome measures Full feeds were achieved later in infants <29 weeks; median age 28 days {IQR 22–40} compared with 19 days {IQR 17–23} in infants ≥29 weeks (HR 0.35, 95% CI 0.3 to 0.5). The incidence of necrotising enterocolitis was also higher in this group; 32/83 (39%) compared to 32/312 (10%) in those ≥29 weeks (RR 3.7, 95% CI 2.4 to 5.7). Infants <29 weeks tolerated very little milk for the first 10 days of life and reached full feeds 9 days later than predicted from the trial regimen. Conclusions Growth-restricted infants born <29 weeks’ gestation with abnormal antenatal Doppler failed to tolerate even the careful feeding regimen of ADEPT. A slower advancement of feeds may be required for these infants. Trial registration number ISRCTN87351483.